OHI OHI
Company Profile ↓Company Overview
OHI (OHI) is a publicly traded company listed on with a market capitalization of $14.39B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 13.5% per year over the last five years.
Maintains a net profit margin of 49.6%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.19B (+13.2% YoY); net profit $590.18M.
- Trailing 12 Months Year-on-year growth — revenue +13.2%, earnings +45.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 3.5%, profit CAGR 13.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 3.54% |
| 1 Year: | 13.19% |
Compounded Profit Growth
| 5 Years: | 13.47% |
| 1 Year: | 45.25% |
Stock Price Performance
| 1 Year: | +28.04% |
| 6 Months: | +18.38% |
| 3 Months: | +7.01% |
| 1 Month: | -0.54% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)48.95 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 49.6%.
- Profit CAGR of 13.5% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 282.51M | 311.59M | 319.22M | 322.95M | 328.25M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.77M | 3.50M | 4.37M | 9.01M | 16.20M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 279.25M | 308.09M | 314.84M | 313.94M | 312.05M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 99.58M | 101.98M | 113.14M | 106.87M | 118.82M |
| Operating Income | 126.07M | - | 96.54M | 142.24M | 124.31M | - | 139.23M | 141.08M | -88.24M | - | 138.13M | 132.68M | 110.67M | - | 122.17M | 126.53M | 187.16M | - | 147.73M | 156.53M | -39.48M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 179.68M | 206.10M | 201.71M | 207.08M | 193.23M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 280.60M | 331.58M | 305.79M | 293.81M | 509.71M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 52.90M | 58.12M | 51.74M | 49.76M | 48.12M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 147.19M | 191.35M | 171.30M | 159.92M | 379.76M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.53M | 4.48M | 2.13M | 5.11M | 4.62M |
| Net Income | 79.40M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 67.36M | 113.86M | 111.76M | - | - | 136.60M | 179.72M | 164.84M | 151.05M | 362.82M |
| Diluted EPS | 0.43 | 0.32 | 0.29 | 0.57 | 0.40 | 0.63 | 0.53 | 0.33 | -0.67 | 0.31 | 0.42 | 0.39 | 0.28 | 0.31 | 0.34 | 0.34 | 0.63 | 0.27 | 0.39 | 0.43 | -0.40 | 0.69 | 0.36 | 0.58 | 0.79 | 0.38 | 0.43 | 0.15 | 0.25 | 0.37 | 0.27 | 0.45 | 0.42 | - | - | 0.46 | 0.59 | 0.55 | 0.47 | 1.19 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | 900.83M | 908.38M | 881.68M | 928.83M | 892.38M | - | 878.24M | 949.74M | 1.05B | 1.19B |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 15.50M | 15.03M | 14.56M | 14.44M |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 862.74M | 934.72M | 1.04B | 1.18B |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 470.47M | 445.74M | 377.17M | 431.72M |
| Operating Income | 104.74M | 115.89M | 148.94M | 137.79M | 214.97M | 265.68M | 345.31M | 411.27M | 559.95M | 315.17M | 497.59M | 551.75M | - | - | 392.28M | 488.97M | 659.66M | 743.94M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00B | 810.84M | 947.11M | 1.16B |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 233.24M | 235.53M | 221.72M | 215.03M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 436.14M | 255.63M | 420.75M | 624.43M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.56M | 6.25M | 10.86M | 14.75M |
| Net Income | 78.14M | 82.11M | 58.44M | 52.61M | 120.70M | 172.52M | 221.35M | 224.52M | 366.42M | 100.42M | 281.58M | 341.12M | 159.33M | - | 426.93M | 242.18M | 406.33M | 590.18M |
| Diluted EPS | 0.94 | 0.87 | 0.52 | 0.46 | 1.12 | 1.46 | 1.74 | 1.29 | 1.90 | 0.51 | 1.40 | 1.58 | 0.70 | - | 1.80 | 1.00 | 1.55 | 1.94 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 1.66B | 2.30B | 2.56B | 2.98B | 3.46B | 3.92B | 7.99B | 8.95B | 8.77B | 8.59B | 9.80B | 9.50B | - | 9.41B | 9.12B | 9.90B | 10.05B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.77B | 2.26B | 2.64B | 2.06B |
| Cash & Equivalents | 1.98M | 209.00K | 2.17M | 6.92M | 351.00K | 1.71M | 2.62M | 4.49M | 5.42M | 93.69M | 85.94M | 10.30M | 24.12M | 163.53M | - | 297.10M | 442.81M | 518.34M | 27.02M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 180.33M | 223.42M | 260.09M | 285.93M |
| Total Liabilities | - | - | 789.81M | 1.30B | 1.68B | 1.97B | 2.16B | 2.52B | 3.89B | 4.74B | 4.89B | 4.83B | 5.46B | 5.46B | - | 5.60B | 5.36B | 5.17B | 4.61B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 334.29M | 308.19M | 328.19M | 594.55M |
| Long Term Debt | - | - | - | 1.18B | 1.55B | 1.82B | 2.02B | 2.38B | 3.57B | 4.37B | 4.57B | 4.54B | 5.14B | 5.17B | - | 5.27B | 5.05B | 4.84B | 4.01B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.29B | 5.07B | 4.84B | 4.26B |
| Total Equity | 586.13M | 787.99M | 865.23M | 1.00B | 878.48M | 1.01B | 1.30B | 1.40B | 3.74B | 3.86B | 3.56B | 3.44B | 4.14B | 3.84B | - | 3.61B | 3.57B | 4.54B | 5.18B |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 234.25M | 245.28M | 279.13M | 295.54M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 89.33M | 147.22M | 157.56M | 169.77M | 208.27M | 279.95M | 337.54M | 463.88M | 624.77M | 577.91M | 499.37M | 553.75M | 708.26M | - | 625.73M | 617.74M | 749.43M | 878.55M |
| Investing Cash Flow | -187.10M | -209.00M | -394.81M | -257.64M | -390.70M | -598.83M | -547.95M | -397.41M | -1.11B | -285.13M | -173.22M | -378.95M | -89.06M | - | 442.85M | -770.00K | -671.16M | -539.79M |
| Financing Cash Flow | 96.00M | 63.74M | 242.00M | 81.30M | 183.79M | 319.79M | 212.28M | -65.32M | 576.30M | -303.81M | -410.70M | -153.96M | -485.55M | - | -789.45M | -473.31M | 26.32M | -838.26M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | - | - | - | -95.06M | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 625.73M | 617.74M | 749.43M | 878.55M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 279.13M | 143.66M | 104.58M | -499.50M |
| Share Buybacks | - | - | - | 2.93M | - | - | - | - | - | - | - | - | - | - | 142.27M | - | - | - |
| Dividends Paid | 98.06M | 109.23M | 138.88M | 161.89M | 182.19M | 218.12M | 258.50M | 358.23M | 453.15M | 502.60M | 528.70M | 564.13M | 612.31M | 637.65M | 632.89M | 643.87M | 685.45M | 780.39M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 98.2% | 98.4% | 98.6% | 98.8% |
| Operating Margin % | - | - | - | - | - | - | - | - | 62.2% | 34.7% | 56.4% | 59.4% | - | - | 44.7% | 51.5% | 62.7% | 62.5% |
| Net Margin % | - | - | - | - | - | - | - | - | 40.7% | 11.1% | 31.9% | 36.7% | 17.9% | - | 48.6% | 25.5% | 38.6% | 49.6% |
| ROE % | 9.9% | 9.5% | 5.8% | 6.0% | 11.9% | 13.3% | 15.8% | 6.0% | 9.5% | 2.8% | 8.2% | 8.2% | 4.1% | - | 11.8% | 6.8% | 9.0% | 11.4% |
| ROCE % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.3% | 5.6% | 6.9% | 7.9% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for OHI
Omega Healthcare Investors (OHI) Stock May Be 47% Undervalued Following Dividend Increase - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxOZk1oNnQ2eWJKY0hneEZrb3VfeEpLWjVzVG5RVGpPVV93Vm1vRmwyd3E0WEEtajhqNDF2YUpzUGY3WXpKc0dTMVM0NEE5TkZVNlNNSlp2TW9WZzltVU1WcDFTSjVIaDhneDV3T1ZINUVjSnZPVXp2TmVHdFFKdklXb0ROWU9NZ3VLWDRLUm…
Omega Healthcare Investors Inc (OHI) Stock Down 3.2% but Still O - GuruFocus
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxPUmRTa0ZieG9xaHhWcU5lYUpGQURTWjFiV2M3b2xRMnFxMGxFaXk3Q2QxeHNrM3NIeC13WG5iRkhWOTVDTDVYNWNuVldyd2ROa3BLWnYzVWdGNzZMRjh2QV9OT1NGcHRwNWlkcDBmQkpuN1JWZnpPQjdxaGJROVFMakM1ZHhOVDR1c0N3dU…
Omega Healthcare Investors (OHI) Stock Faces Tenant Doubts Despite Steady FFO - Sahm
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQU2hfekdHemhLSXprOWdycGFYMEN6VHA1NWVXczhjVllkc3ZudlI1MktBdGk3TndBU2RDQVpyVEZKZWdBSlR6aWs5Wk9kT05VWmdQS3pMeTVnZGM5aEtUNVNZcGNzNEEwc0dsVkt6aFRYcHlGdjRJeXR5cVFTSkJtcjRlRVhTSjlxWDNYbW…
Omega Healthcare Investors (OHI) Stock May Still Trade Below Fair Value - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxPeTR2aEwxQk41M2FjNDJROUJ3MUtzakpRMG10OGdJX0F6RGpUcUc2WDBiM0x0cFF3NXpfaDktcnRCakNhVE9QUHJybGdYc0h0Z3ZEekRydmNoR0tmbEdjSVp3U1VYQVlZRWU5a1NXdEtQc0tsb3FWM20ybUQ0TjRScDNTa0JMbDhTWGhJN1…
Omega Healthcare Investors' Dividend Rises 1 Cent to $0.68 - Stock Titan
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQb0pGRkJZR3d3MDZsVXBpMWJuaER5aWl6UkNpTmJhdmJqcmlIbmNRdGtPT0lnSmdwNklfYlJJYmZ6My1ISUYwWDJoRUx0cHU4Rm16SWt1MGVsUm1rdE5SRDZiS1g0MzhmdVNWVFF1cjZUdy1JQm8zelg0RDdYWXd4Vm9reVNtc1R2YklOOW…
7-Day Sell-Off Sends Omega Healthcare Investors Stock Down -9.7% - Trefis
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPTnlrQXBJQV9qQjJZMW9GOW5jUnRpMjlSRk03X3BfN2tySWpXajl3YTlkaHJac3IwckNoMHRjT0lLQ2ZZT0Q0RktMeVdfVG9BLVNjbm1wUS1IWXBQOG4wazNRV2lXY0ZVWjZGWkVib1MxNHd4U0RabjBwZmRENUROakZhalFkZ1MwZGVmZW…
OHI — Frequently Asked Questions
What is the current share price of OHI?
As of 2026-08-05 17:25 PDT, OHI trades at $48.69 on NASDAQ/NYSE. Its 52-week range is $37.16 to $51.03.
What is the market capitalisation of OHI?
OHI has a market capitalisation of $14.39B on NASDAQ/NYSE.
What is the P/E ratio of OHI?
OHI trades at a trailing price-to-earnings (P/E) ratio of 25.10. Its price-to-book (P/B) ratio is 2.78.
What is the return on equity (ROE) of OHI?
OHI has a return on equity (ROE) of 11.39%. Its return on capital employed (ROCE) is 7.87%.
Is OHI a good stock to buy?
This page provides a data-driven analysis of OHI, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.